About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

24

Nov

2015

NCPA Survey: What's Important to You?

NCPA is asking members to tell them where to focus the majority of their time and energy serving the membership by filling out a short six-question survey which will take less than 10 minutes to complete.

Read More...

24

Nov

2015

Launch of generic Mirapex ER

Par Pharmaceutical launched the generic equivalent of 2.25 MG strength of Mirapex ER® (pramipexole dihydrochloride) extended-release tablets. The Par item will be added to the OneStop program in the A*- slot, with visibility in McKesson Connect on Tuesday, November 24, 2015.

Read More...

24

Nov

2015

US Script: Auvi-Q (epinephrine injection, USP) RECALL

Effective: October 29, 2015

The Federal Drug Administration (FDA) issued a press release to the wholesale, retail, user, hospital, and consumer level on October 29, 2015 involving:

Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP)

• All Auvi-Q currently on the market including both the 0.15 mg and 0.3 mg strengths for hospitals, retailers, and consumers. This includes lot number 2299596 through 3037230, which expire March 2016 through December 2016.

• This recall has been initiated due to the products being found to potentially have inaccurate dosage delivery.

If a patient experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death because anaphylaxis is a potentially life-threatening condition.

Immediately examine your inventory and quarantine any product subject to recall. In addition, if you may have further distributed this product past the recall date, please identify your affected customers and notify them at once of this product recall. We look forward to working together to provide quality pharmacy services to our members.

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm470010.htm

Read More...

24

Nov

2015

CVS/caremark: New Implementation for HealthChoice Oklahoma

Effective: January 1, 2016

Effective January 1, 2016, CVS/caremark will begin to administer the prescription benefits for HealthChoice Oklahoma. Please update or create plan member profiles to reflect the changes regarding the following new plan adjudicating through CVS/caremark.

RXBIN: 004336

RXPCN: ADV

RXGRP: RX1147, RX1149

Member ID Format 8 digits

Person Code not required

Read More...

24

Nov

2015

Gateway Pharmacy Networks & Citizens RX: New Group forLousiana State University/LSU

Effective: January 1, 2016

Dear Valued Pharmacy Provider:

Effective January 1, 2016, Citizens RX is pleased to announce that we will begin administering the pharmacy benefit program for the Louisiana State University (LSU).

Please ensure that you have this BIN activated in your store system prior to January 1, 2016.

Read More...
First831833Last